What is NDC 11673-840?

11673-840 is the product NDC for Guaifenesin, Guaifenesin 1200 mg/1 tablet, listed with the FDA by TARGET CORPORATION. It has 2 package NDCs, shown above in 10- and 11-digit form.

TARGET CORPORATION, NDC labeler code 11673. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Guaifenesin?

61 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Guaifenesin NDC 11673-840 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)11673-840Labeler and product segments. Claims need a package NDC.

Product NDC at billing width11673-0840Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
11673-840-27	1167308402711673084027	14 TABLET in 1 BLISTER PACK (11673-840-27)Marketed from Aug 1, 2024
11673-840-28	1167308402811673084028	28 TABLET in 1 BLISTER PACK (11673-840-28)Marketed from Aug 1, 2024

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Guaifenesin
Generic name (nonproprietary): guaifenesin
Active ingredients: Guaifenesin — 1200 mg/1
Dosage form: Tablet
Route: Oral
Labeler: TARGET CORPORATIONNDC labeler code 11673
Product type: Over-the-counter drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 213420
Marketing start: Aug 1, 2024
Listing expires: Dec 31, 2026
Other FDA classes: Decreased Respiratory Secretion Viscosity (Physiologic effect)Increased Respiratory Secretions (Physiologic effect)
Identifiers: Product ID 11673-840_46533235-e333-d722-e063-6294a90aeba9SPL ID 46533235-e333-d722-e063-6294a90aeba9SPL set ID 09957814-61e2-4488-e063-6294a90a2201RxCUI 310621UNII 495W7451VQ
Pharmacologic class: Expectorant

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N411673084027 followed by a unit qualifier and the quantity

Package 11673-0840-27. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Dec 19, 2025.

Indications (excerpt from the label)

Uses helps loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus and make coughs more productive

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 11673-840

What is NDC 11673-840?: 11673-840 is the product NDC for Guaifenesin, Guaifenesin 1200 mg/1 tablet, listed with the FDA by TARGET CORPORATION. It has 2 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Guaifenesin.
What is the active ingredient?: Guaifenesin.
Who is the labeler?: TARGET CORPORATION, NDC labeler code 11673. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Guaifenesin?: 61 other product NDCs are listed under this name. See all Guaifenesin NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Guaifenesin NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Guaifenesin	Guaifenesin 1200 mg/1	Tablet, Extended releaseOral	Aurohealth LLC	58602-857	58602-0857-93
Guaifenesinguaifenesin 400 mg	Guaifenesin 400 mg/1	TabletOral	Zennova LLC	81993-002	81993-0002-0181993-0002-0281993-0002-03+2 more
Guaifenesin	Guaifenesin 1200 mg/1	Tablet, Extended releaseOral	TOPCO ASSOCIATES LLC	76162-031	76162-0031-56
Guaifenesin	Guaifenesin 600 mg/1	TabletOral	YYBA CORP	73581-400	73581-0400-0273581-0400-07
Guaifenesin	Guaifenesin 1200 mg/1	Tablet, Extended releaseOral	Sam's West Inc	68196-960	68196-0960-56
Guaifenesin	Guaifenesin 100 mg/5mL	SolutionOral	American Health Packaging	60687-852	60687-0852-17
Guaifenesin	Guaifenesin 200 mg/10mL	SolutionOral	American Health Packaging	60687-863	60687-0863-56
Guaifenesin	Guaifenesin 300 mg/15mL	SolutionOral	American Health Packaging	60687-874	60687-0874-16
Guaifenesin	Guaifenesin 1200 mg/1	Tablet, Extended releaseOral	GRANULES USA, INC.	69848-018	69848-0018-16
Guaifenesin	Guaifenesin 600 mg/1	TabletOral	TARGET CORPORATION	11673-539	11673-0539-02

All 62 Guaifenesin NDCs

Other NDCs under ANDA 213420

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 213420
Product	Strength	Form · route	Labeler	Product NDC
Mucus Reliefguaifenesin	Guaifenesin 600 mg/1	TabletOral	Bi-Mart	37835-408
Mucus Reliefguaifenesin	Guaifenesin 1200 mg/1	Tablet, Extended releaseOral	Bi-Mart	37835-412
Guaifenesin	Guaifenesin 1200 mg/1	TabletOral	Walgreens	0363-0570
Guaifenesin	Guaifenesin 600 mg/1	TabletOral	Walgreens	0363-9569
Mucus Reliefguaifenesin	Guaifenesin 600 mg/1	Tablet, Extended releaseOral	AAA Pharmaceutical, Inc.	57344-203
Guaifenesin	Guaifenesin 1200 mg/1	TabletOral	SAM'S WEST INC	68196-405
Guaifenesin	Guaifenesin 1200 mg/1	Tablet, Extended releaseOral	CVS PHARMACY, INC	69842-335
Mucus Reliefguaifenesin	Guaifenesin 600 mg/1	Tablet, Extended releaseOral	Advanced Rx LLC	80513-403
Good Sense Mucus ERguaifenesin	Guaifenesin 1200 mg/1	Tablet, Multilayer, Extended releaseOral	L. Perrigo Company	0113-3650
Guaifenesin	Guaifenesin 1200 mg/1	Tablet, Extended releaseOral	Advanced Rx LLC	80513-413
Guaifenesin	Guaifenesin 1200 mg/1	Tablet, Extended releaseOral	Granules India Ltd	62207-569
Guaifenesin	Guaifenesin 600 mg/1	Tablet, Extended releaseOral	Granules India Ltd	62207-570
Crcle Guaifenesin Extended-Release Tablets, 600 mgguaifenesin extended-release	Guaifenesin 600 mg/1	TabletOral	Innovus Pharmaceuticals, Inc.	57483-270
Crcle Guaifensin Extended Release Tablet, 1200 mgguaifensin extended-release	Guaifenesin 1200 mg/1	TabletOral	Innovus Pharmaceuticals, Inc.	57483-280
Mucus Reliefguaifenesin	Guaifenesin 1200 mg/1	Tablet, Extended releaseOral	CHAIN DRUG MARKETING ASSOCIATION, INC.	83324-096
Mucus Reliefguaifenesin	Guaifenesin 600 mg/1	Tablet, Extended releaseOral	CHAIN DRUG MARKETING ASSOCIATION, INC.	83324-097
Mucus Reliefguaifenesin	Guaifenesin 600 mg/1	Tablet, Extended releaseOral	Demoulas Super Markets, Inc	53942-203
Mucus Relief Maximum Strengthguaifenesin	Guaifenesin 1200 mg/1	Tablet, Extended releaseOral	Demoulas Super Markets, Inc	53942-204
Maximum Strength Mucus Reliefguaifenesin	Guaifenesin 1200 mg/1	Tablet, Extended releaseOral	CHAIN DRUG MARKETING ASSOCIATION INC	63868-148
Guaifenesin	Guaifenesin 600 mg/1	Tablet, Extended releaseOral	GRANULES PHARMACEUTICALS INC.	70010-199

Showing 20 of 39.